Cartiva Announces FDA Premarket Approval for Cartiva Synthetic Cartilage Implant

Cartiva received FDA Premarket Approval for the Synthetic Cartilage Implant (SCI) to treat arthritis of the great toe, representing what is reported to be the first synthetic cartilage device to gain FDA approval. Product introduction will occur at the American Orthopaedic Foot and Ankle Society Annual Meeting in July 2016.

The approval...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0